POSSIBILITIES FOR EXPANDING THE INDICATIONS FOR CHEMOTHERAPY OF UTERINE CANCER by Georgieva, Zh. et al.
Scripta Scientifica Medica, vol. 32 (2000), pp 31-33 Copyright © Medical University, Varna 
POSSIBILITIES FOR EXPANDING THE INDICATIONS 
FOR CHEMOTHERAPY OF UTERINE CANCER 
Zh. Georgieva, K. Nenova, H. Tsekov, D. Mazhdrakova 
Department of Propedeutics of Internal Medicine, Medical University of Varna 
A B S T R A C T 
Incidence rate of myocardial dysfunction in females operated on the occasion of uterine cancer and with mani­
festations of symptomatic chronic iron-deficiency anemia (IDA) of moderate or severe degree was studied. A 
diagnostic test for early diagnosis and dynamic monitoring of the left-ventricular dysfunction aiming at en­
larging the chemotherapeutic indications was suggested. The left ventricular dysfunction registered accord­
ing to echocardiographic criteria in 56 patients with uterine cancer and IDA required correction of the 
chronic anemic hypoxia prior to chemotherapy. Echocardiographically, there was a reversibility of left ven­
tricular volume loading in 82 per cent of the cases (p < 0,001) after anemia correction. Chemotherapy adminis­
tration was enabled after achieving the definite values of left ventricular dimension using a dynamic 
echocardiographic control. The early diagnosis of the myocardial dysfunction and its timely correction al­
lowed not only the optimization of the chemotherapy but also the expansion of its indications. 
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I N T R O D U C T I O N 
Uterine cancers {Carcinoma colli uteri, Carcinoma 
corporis uteri) are often accompanied by chronic 
posthemorrhagic iron-deficiency anemia (IDA). The ane­
mia aggravates after the surgical intervention of the cancer 
and thus represents a serious challenge prior to chemother­
apy initialization. The chronic IDA provokes the conditions 
of chronic anemic hypoxia affecting the cardiovascular sys­
tem (1,2,6). 
Defining the incidence rate of myocardial dysfunction in 
uterine cancers accompanied by chronic ША should be 
done prior to chemotherapy, especially in cases given 
drugs displaying certain cardiac toxicity. 
The purpose of the present work is to study the changes of 
the left-ventricular function in females operated on the 
occasion of uterine cervix and symptomatic ЮА prior to 
the onset of chemotherapy. The following tasks have to be 
solved: 
1. To examine the incidence rate of the myocardial dys­
function in operated patients with moderate or severe de­
gree of D A . 
2. To suggest a test for early diagnosis and dynamic control 
of left ventricular function in these patients. 
3. To analyze the extent of correction of the myocardial al­
terations after treatment of iron deficiency. 
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M A T E R I A L AND M E T H O D S 
A total of 116 females operated on the occasion of uterine 
cancer presenting with chronic ЮА and at medium age of 
45,6 ± 5,7 years were studied. Etiologically, ЮА resulted 
from metrorrhagies which duration was longer than 6 
months. Data were matched with a control group of 43 
healthy women at medium age of 44,6 ±3,4 years. The fe­
males were divided into groups without and with ЮА. The 
different levels of hemoglobin and serum iron were demon­
strated on Table 1. 
Table 1. Hemoglobin and serum iron values in IDA 
patients and controls 
Groups n Hb(grt) Serum iron (mkmol/1) 
Healthy 43 128 ±1,35 14,58 ±1,42 
Moderate degree of IDA 55 89,44 ±1,32 8,06 ±2,13 
Severe degree of IDA 61 69,32 ±2,04 6,54 ±1,90 
Echocardiographic (EchoCG) examination using Toshiba 
SSH-160A echographic unit was carried out in any women 
to assess the left ventricular function. In the patients with 
EDA, this was done prior to the management of the anemia 
and after a parenteral administration of Ferrum Hausman 
and blood transfusions for 28 ± 3 days. 
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R E S U L T S A N D D I S C U S S I O N 
The EchoCG test for the dynamic monitoring of the left 
ventricular function suggested by us indicated that signs of 
initial left-ventricular dysfunction were detected already 
with the moderate degree of D A . Left ventricular dimen­
sion augmented when compared with the control one, e. g., 
its end diastolic dimension - by 14,02 per cent and its end 
systolic one - by 27,57 per cent. There was a proportional 
enlargement of the volumes, too: of the end diastolic vol­
ume ( L V E D V ) - by 47,.98 per cent and of the end systolic 
one ( L V E S V ) - by 106,87 per cent. These results were sta­
tistically significant (p < 0,001). Stroke volume increased 
by 22,61 per cent (p < 0,02). The contractility parameters 
were statistically insignificantly changed as followed: 
shortening fraction decreased by 7,45 per cent but ejection 
fraction - by 11,74 per cent (p > 0,05) (Table 2). 
Table 2. Left ventricular echographic parameters prior to 
treatment 
Parameters Healthy (n=43) 
Moderate degree 
of IDA (n=55) 
Severe degree 
of IDA (n=61) 
LVEDD (cm) 4,92 + 0,23 5,61 ±0,26 5,93 ±0,28 
iLVESD(cm) 3,30 + 0,15 4,21 ±0,18 4,57 ±0,20 
EDV(cm3) 118,88 ±3,65 175,93 ±4,62 207,86 ±5,21 
ESV(cm3) 35,76 ±1,23 73,98 ±2,34 95,08 ±2,77 
blSV (ml) 83,22 ± 3,54 102,04 ±3,65 112,78 ±4,15 
SF(%) 32,72 ±2,20 25,27 ±2,80 23,04 ±2,50 
E F ( % ) 69,75 ± 3,80 58,01 ±4,30 54,28 ±3,50 
kVith aggravating anemia in IDA of severe degree, there 
vas a left ventricular dilatation and volume loading. In this 
)atients' group, the end diastolic dimension of the left 
'entricle increased by 20,52 per cent and the end systolic 
me - by 38,48 per cent (p < 0,001). A significant increase of 
-DV (by 74,84 per cent), of E S V (by 165,88 per cent), and 
f the stroke volume (by 35,52 per cent) at p < 0,001 was 
^gistered. The contractility parameters significantly 
iminished under the lower limits of nomograms as 
allowed: shortening fraction - by 9,68 per cent and ejection 
action - by 15,47 per cent (p < 0,001). 
. 28-day long active treatment for iron deficiency 
)rrection of the moderate degree of ША registered in 26,2 
:r cent of the patients resulted in complete involution of 
е myocardial dysfunction presenting with normalized 
:hoCG parameters. 
manifested left-ventricular dysfunction was 
hographically registered in 66,72 per cent of the patients 
ith severe degree of IDA. The treatment failed, however, 
normalize the values of these parameters. There was a 
layed course of reversibility in this group. After the 
28-day long treatment the values of the dimensions and vol­
umes of the left ventricle remained over the upper-limit 
ones according to Feigenbaum's nomograms. In the severe 
degree of IDA, the values of the contractility parameters re­
mained lower than in the control group after treatment: of 
the shortening fraction by 7,61 per cent and of the ejection 
fraction by 11,98 per cent (Table 3). 
Table 3. Left ventricular echographic parameters after 
treatment 
Parameters Moderate degree oflDA(n=55) 
Severe degree 
ofIDA(n=61) 
LVEDD (cm) 5,40 ±0,25 5,67 ±0,27 
LVESD(cm) 3,82 ±0,17 4,26 ±0,19 
EDV(cm3) 156,98 ±3,78 183,10±4,23 
ESV (cm3) 55,88 ± 1,96 77,04 ±2,12 
SV (ml) 101,02 ±3,43 106,48 ±3,95 
rinOSF(%) 29,21 ±2,04 25,11 ±2,10 
E F ( % ) 63,85 ±3,70 57,77 ±3,60 
Our investigation allows us to accept that in the patients 
with IDA of moderate and severe degree certain functional 
myocardial changes set in directly correlating with the de­
gree of IDA (1,4,5). Under the conditions of overloaded left 
ventricular volumes in both groups of IDA a hyperdynamic 
heart-work regimen with enhanced stroke volume has been 
established According to Varat (6), the anemic hypoxia in 
IDA is responsible for the increased stroke and minute vol­
umes and the hyperdynamic heart-work regimen. These 
authors accept that the increasing of these volumes could be 
considered the earliest adaptation mechanism involved un­
der the conditions of anemic hypoxia. The reduction of he­
moglobin values in the peripheral blood presents with a ten­
dency towards left ventricle augmentation and even dilata­
tion in the severe degree of IDA. However, in both patients' 
groups the left ventricular volumes increase significantly. 
Gupta et al. established a strong correlation between the 
decreased hemoglobin values and the increased left 
ventricular volumes (3,4). 
Total myocardial oxygen uptake depends to a great extent 
on the diastolic volume of the left ventricle. The increase of 
E D V in severe IDA patients up to 207,86 ± 5,21 determines 
a higher energy work level of the dilated left ventricle caus­
ing an elevated myocardial oxygen demand without any 
improvement of its effectiveness. There is a more signifi­
cant reduction of the contractility parameters such as E F as 
compared to the controls. 
Proper iron deficiency correction leads to an outlined re­
versibility of the echocardiographic changes in the moder­
ate degree of IDA but to a delayed course of reversibility in 
the severe degree of IDA that should be taken into consider­
ation prior to chemotherapy administration. 
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C O N C L U S I O N S 
1. The chronic ЮА provokes a hyperdynamic heart-work 
regimen with enlarged left ventricle dimensions and vol­
umes along with a discrete reduction of its contractile func­
tion. 
2. The encountered left ventricular dysfunction requires ac­
tive parenteral treatment aiming at correcting the iron defi­
ciency. 
The dynamic echocardiographic monitoring is necessary 
for the patients with severe degree of ЮА prior to chemo­
therapy aclministration and during the chemotherapeutic 
course rendering an account of the delayed reversibility of 
the left ventricular changes caused by the IDA. 
3. It is recommended to start chemotherapy only in these 
patients with accompanying chronic IDA who have already 
reached the lower limits of the shortening and ejection frac­
tions of the left ventricle. 
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